Section 13-7A-01 - Definitions(a) In this subtitle the following words have the meanings indicated.(b) "Agent" means an individual who:(1) Is at least 18 years of age;(2) Has successfully completed, at the expense of the participating facility, an educational training program approved by the Department under § 13-7A-03 of this subtitle; and(3) Is designated by a certificate holder to administer auto-injectable epinephrine in accordance with the provisions of this subtitle.(c) "Anaphylaxis" means a sudden, severe, and potentially life-threatening allergic reaction that occurs when an individual is exposed to an allergen.(d) "Auto-injectable epinephrine" means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.(e) "Certificate" means a certificate issued by the Department to an individual to obtain, store, and administer auto-injectable epinephrine.(f) "Certificate holder" means an individual who is authorized by the Department to obtain, store, and administer auto-injectable epinephrine to be used in an emergency situation.(g) "Eligible institution" means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that is authorized under this subtitle to obtain and store auto-injectable epinephrine.(h) "Food service facility" has the meaning indicated in § 21-301 of this article.(i) "Participating facility" means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.(j) "Program" means the Emergency Use Auto-Injectable Epinephrine Program established under § 13-7A-02 of this subtitle.Amended by 2020 Md. Laws, Ch. 479,Sec. 1, eff. 10/1/2020.Amended by 2020 Md. Laws, Ch. 478,Sec. 1, eff. 10/1/2020.Added by 2018 Md. Laws, Ch. 527,Sec. 1, eff. 10/1/2018.